Therapeutic safety and efficacy of triple-immunosuppressants versus dual-immunosuppressants in severe-to-critical COVID-19: a prospective cohort study in Bangladesh

Hasan, MJ; Rabbani, R; Anam, AM; Huq, SMR

Hasan, MJ (通讯作者)，Sq Hosp Lt, Dept Pharm, Coordinator Clin Pharm, Clin Pharmacist Crit Care & Infect Dis Stewardshi, 18-F Bir Uttam Qazi Nuruzzaman Sarak, Dhaka 1205, Bangladesh.

ANNALS OF MEDICINE, 2022; 54 (1): 723

Abstract

Background Hyperinflammation-induced respiratory failure is a leading cause of mortality in COVID-19 infection. Immunosuppressants such as, Baricitini......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索